Hakluyt Capital announces three new investments December 2024

Hakluyt Capital has announced three new investments completed during the second half of 2024. This comes after the first fund reached its final close in February, exceeding the target raise of $50 million.

These three new portfolio companies are:

Sword Health, a healthcare company pioneering AI Care, which combines the expertise of world-class clinicians with an interactive AI experience to deliver care that members can use anywhere, anytime.

Aven, a technology-led innovator in consumer finance whose initial product is a credit card backed by home equity.

Tenstorrent, a next-generation computing company that is developing high-performance hardware and software solutions optimised for running AI and machine learning workloads.

Nick Bidmead, a founding partner of Hakluyt Capital, said: “We are delighted to have invested in these three pioneering companies. Hakluyt Capital’s mission is to identify and work with the most innovative and inspiring growth-stage companies, and Sword Health, Aven and Tenstorrent are excellent additions to our portfolio.”

Jamie Potts, another founding partner, added: “Sword Health, Aven, and Tenstorrent have already developed leading innovations in their respective industries. We are looking forward to working with them and drawing on Hakluyt’s in-house expertise and network to help them navigate the strategic opportunities and challenges they face as they continue to grow.”

Hakluyt Capital, which was founded in 2022, invests alongside leading venture capital funds, targeting Series B to D companies with high growth potential and international ambitions. The current fund has now invested a little over half of its committed capital.